SPRUCE BIOSCIENCES, INC.

For the period ended Dec 31, 2024. Filed Apr 15, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Apr 15, 2025

SPRB$49.34+6.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Balance Sheets

(in thousands, except share and per share amounts)

	December 31,
	2024	2023
ASSETS
Current assets:
Cash and cash equivalents	$38,753	$96,339
Prepaid expenses	3,177	3,876
Other current assets	2,276	1,968
Total current assets	44,206	102,183
Right-of-use assets	934	1,181
Other assets	69	582
Total assets	$45,209	$103,946
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$1,295	$3,332
Accrued expenses and other current liabilities	12,329	14,600
Term loan, current portion	1,622	1,622
Deferred revenue	—	4,911
Total current liabilities	15,246	24,465
Lease liabilities, net of current portion	736	1,019
Term loan, net of current portion	124	1,717
Other liabilities	282	236
Total liabilities	16,388	27,437
Commitments and contingencies (Note 7)
Stockholders’ equity:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized and no shares issued or outstanding as of December 31, 2024 and 2023	—	—
Common stock, $0.0001 par value; 200,000,000 shares authorized as of December 31, 2024 and 2023; 42,231,285 and 41,029,832 shares issued and outstanding as of December 31, 2024 and 2023, respectively	4	4
Additional paid-in capital	279,085	273,737
Accumulated deficit	(250,268)	(197,232)
Total stockholders’ equity	28,821	76,509
Total liabilities and stockholders’ equity	$45,209	$103,946

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.